<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR102">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Komiyama</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Fuller</surname>
    <given-names>RS</given-names>
   </name>
  </person-group>
  <article-title>Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin</article-title>
  <source>Biochemistry</source>
  <year>2000</year>
  <volume>39</volume>
  <fpage>15156</fpage>
  <lpage>15165</lpage>
  <pub-id pub-id-type="doi">10.1021/bi001907c</pub-id>
  <?supplied-pmid 11106495?>
  <pub-id pub-id-type="pmid">11106495</pub-id>
 </element-citation>
</ref>
